Clinical Trials

450 enrolled

Carcinoma, Renal Cell, von Hippel-Lindau Disease

NCT03091192 2026-04-14

Savolitinib vs. Sunitinib in MET-driven PRCC.

60 enrolled 15 charts

Carcinoma, Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Neoplasms by Site, Urologic Neoplasms

NCT01575548 2026-04-13

Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery

129 enrolled 11 charts

Carcinoma, Renal Cell

NCT03055013 2026-04-13

Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy

819 enrolled 12 charts

Carcinoma, Renal Cell

NCT03793166 2026-04-13

Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

1,175 enrolled

Carcinoma, Renal Cell, Lymphatic Metastasis

NCT06661720 2026-04-07

STRIKE

1,040 enrolled

Carcinoma, Renal Cell

NCT05863351 2026-04-03

Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study

472 enrolled

Carcinoma, Renal Cell

NCT06500455 2026-04-03

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

BreastCNSDermatologicGenitourinaryThoracic

269 enrolled

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Lung Neoplasms, Melanoma, Neoplasm Metastasis

NCT07197580 2026-04-01

LUTEON

40 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms, Recurrence

NCT03815643 2026-03-31

Avelumab Program Rollover Study

GenitourinaryGynecologicThoracic

205 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Ovarian Neoplasms

NCT07489495 2026-03-24

LITESPARK-034

Phase 3 Not yet recruiting

758 enrolled

Carcinoma, Renal Cell

NCT04338269 2026-03-19

CONTACT-03

Phase 3 Terminated

522 enrolled 22 charts

Carcinoma, Renal Cell

NCT05738694 2026-03-17

Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma

298 enrolled

994 enrolled 10 charts 2 FDA

Carcinoma, Renal Cell

NCT03142334 2026-03-10

KEYNOTE-564

Phase 3 Completed

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Renal Cell

NCT07000149 2026-03-10

eVOLVE-RCC02

1,116 enrolled

Diabetes Mellitus, Insulin-Dependent, 12, Carcinoma, Renal Cell, Kidney Neoplasms

NCT04586231 2026-03-05

MK-6482-011

747 enrolled

Phase 3 Not yet recruiting

Carcinoma, Renal Cell

NCT06959433 2026-02-27

Lu-177 PSMA Treatment in Cell Renal Carcinoma

20 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT02811861 2026-02-23

CLEAR

1,069 enrolled 12 charts 2 FDA

Phase 3 Not yet recruiting

Carcinoma, Renal Cell

NCT07383441 2026-02-03

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

718 enrolled

861 enrolled 24 charts 2 FDA

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT02853331 2026-02-02

KEYNOTE-426

Phase 3 Completed

Carcinoma, Renal Cell

NCT03873402 2026-01-21

A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer

437 enrolled

Carcinoma, Renal Cell

NCT07092566 2026-01-20

R.E.C.K vs Exparel in Robotic Nephrectomy

170 enrolled